Rebecca Gerber joined the Office for Technology Commercialization in 2008 after spending 10 years in various pharmaceutical market analysis and research and scientific affairs roles. While working in the pharmaceutical industry, she primarily focused on conducting market assessments and financial forecasts for early-stage compounds as well as scientific and commercial message development.
Rebecca holds MBA and M.S. degrees from the University of Maryland as well as a B.S. degree in microbiology from Iowa State University.
See a list of available U of M technologies.